DK0949920T3 - Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demens - Google Patents
Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demensInfo
- Publication number
- DK0949920T3 DK0949920T3 DK98933230T DK98933230T DK0949920T3 DK 0949920 T3 DK0949920 T3 DK 0949920T3 DK 98933230 T DK98933230 T DK 98933230T DK 98933230 T DK98933230 T DK 98933230T DK 0949920 T3 DK0949920 T3 DK 0949920T3
- Authority
- DK
- Denmark
- Prior art keywords
- alzheimer
- disease
- dementia
- diagnosis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5208797P | 1997-07-09 | 1997-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0949920T3 true DK0949920T3 (da) | 2006-04-18 |
Family
ID=21975382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98933230T DK0949920T3 (da) | 1997-07-09 | 1998-07-09 | Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demens |
Country Status (17)
Country | Link |
---|---|
US (2) | US6410747B1 (de) |
EP (1) | EP0949920B1 (de) |
JP (1) | JP4522499B2 (de) |
AT (1) | ATE311876T1 (de) |
AU (1) | AU749088C (de) |
BR (1) | BR9806184A (de) |
CA (1) | CA2264750C (de) |
CZ (1) | CZ297533B6 (de) |
DE (1) | DE69832688T2 (de) |
DK (1) | DK0949920T3 (de) |
ES (1) | ES2255170T3 (de) |
HU (1) | HUP0003852A3 (de) |
IL (2) | IL128877A0 (de) |
MX (1) | MXPA04001462A (de) |
PL (1) | PL191402B1 (de) |
SI (1) | SI0949920T1 (de) |
WO (1) | WO1999002154A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6488280B1 (en) * | 2000-09-27 | 2002-12-03 | Milestone Entertainment | Games, and methods and apparatus for game play in games of chance |
CA2465534C (en) * | 2000-11-02 | 2009-10-27 | Nigel H. Greig | Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof |
AU2004285893B2 (en) * | 2003-10-21 | 2011-12-15 | Colucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
CA2553033A1 (en) * | 2004-01-30 | 2005-08-18 | Axonyx, Inc. | Methods for treatment of complications of diabetes |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
CA2509265A1 (en) * | 2004-06-08 | 2005-12-08 | Axonyx, Inc. | Methods of delaying alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and hmg coa reductase inhibitor |
JPWO2006004201A1 (ja) * | 2004-07-01 | 2008-04-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 神経再生促進剤 |
US20060105940A1 (en) * | 2004-11-03 | 2006-05-18 | Axonyx, Inc. | Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methods |
US20060194723A1 (en) * | 2005-02-28 | 2006-08-31 | Rabinoff Michael D | Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
KR100701798B1 (ko) | 2005-05-04 | 2007-03-30 | 라이브켐 주식회사 | 해조식물로부터 추출한 콜린에스터라제 활성 억제제를함유하는 알츠하이머성 치매 개선제 및 인지능력 개선제 |
US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
US20070167509A1 (en) * | 2005-06-14 | 2007-07-19 | Joseph Araujo | Use of phenserine and analogs to treat behavioral problems and improve trainability |
US20100069337A1 (en) * | 2006-10-31 | 2010-03-18 | Acey Roger A | Butyrylcholinesterase inhibitors |
US9757399B2 (en) | 2006-10-31 | 2017-09-12 | Jal Therapeutics, Inc. | Butyrylcholinesterase inhibitors |
CA2693110A1 (en) * | 2007-07-18 | 2009-01-22 | Colucid Pharmaceuticals, Inc. | Methods for promoting wakefulness |
MX344177B (es) | 2008-03-27 | 2016-12-08 | Chase Pharmaceuticals Corp | Uso y composicion para tratar la demencia. |
US8795630B2 (en) | 2008-08-29 | 2014-08-05 | Treventis Corporation | Butyrylcholinesterase ligands as diagnostic tools and treatment for diseases of the nervous system |
WO2010067594A1 (ja) * | 2008-12-11 | 2010-06-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘキサヒドロピロロインドール誘導体 |
US8892184B2 (en) | 2010-10-18 | 2014-11-18 | Siemens Medical Solutions Usa, Inc. | Systems and methods for reducing interference in a dual modality imaging system |
US20120225922A1 (en) | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
EA038489B1 (ru) | 2012-09-05 | 2021-09-06 | Чейс Фамасьютикалз Корпорейшн | Антихолинэргическая нейропротективная композиция и способы |
KR101667215B1 (ko) | 2014-10-21 | 2016-10-18 | 한밭대학교 산학협력단 | 신규한 트립타민 컨쥬게이트 화합물 및 그의 용도 |
US10149828B2 (en) | 2015-01-09 | 2018-12-11 | Chase Pharmaceuticals Corporation | Oxybutynin transdermal therapeutic system combination |
CA2994974C (en) | 2015-08-14 | 2024-04-09 | Qr Pharma | Methods of treatment or prevention of acute brain or nerve injuries |
US20180338950A1 (en) | 2017-05-24 | 2018-11-29 | Qr Pharma, Inc. | Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis Via Administration of Posiphen to Healthy or Sick Humans |
CN109535157B (zh) * | 2018-12-03 | 2021-10-15 | 江苏科技大学 | 一种半蜡梅碱类似物、其合成方法及其用途 |
KR102233120B1 (ko) | 2018-12-18 | 2021-03-29 | 한밭대학교 산학협력단 | 신규한 파에오놀-트립타민 화합물 및 그의 용도 |
US20230113944A1 (en) * | 2020-01-10 | 2023-04-13 | The Regents Of The University Of California | Compositions and methods for the treatment of neurodegenerative diseases |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
US4900748A (en) * | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
DK0605474T3 (da) * | 1991-09-26 | 2004-02-23 | Us Gov Health & Human Serv | Carbamatanaloger af thiaphysovenin, farmaceutiske præparater og fremgangsmåder til inhibering af cholinesteraser |
US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
EP0606366B1 (de) * | 1991-09-26 | 2003-06-04 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES | Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren |
US5409948A (en) * | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
US5783584A (en) * | 1995-12-11 | 1998-07-21 | Mayo Foundation For Medical Education And Research | THA analogs useful as cholinesterase inhibitors |
EP1603365A1 (de) * | 2002-03-12 | 2005-12-07 | Matsushita Electric Industrial Co., Ltd. | Hochfrequenzheizvorrichtung und Steuerungsverfahren derselben. |
-
1998
- 1998-07-09 EP EP98933230A patent/EP0949920B1/de not_active Expired - Lifetime
- 1998-07-09 WO PCT/US1998/014063 patent/WO1999002154A1/en active IP Right Grant
- 1998-07-09 BR BR9806184-4A patent/BR9806184A/pt active Search and Examination
- 1998-07-09 AU AU82931/98A patent/AU749088C/en not_active Ceased
- 1998-07-09 DK DK98933230T patent/DK0949920T3/da active
- 1998-07-09 JP JP50884999A patent/JP4522499B2/ja not_active Expired - Fee Related
- 1998-07-09 CA CA002264750A patent/CA2264750C/en not_active Expired - Fee Related
- 1998-07-09 CZ CZ0081699A patent/CZ297533B6/cs not_active IP Right Cessation
- 1998-07-09 HU HU0003852A patent/HUP0003852A3/hu unknown
- 1998-07-09 SI SI9830820T patent/SI0949920T1/sl unknown
- 1998-07-09 DE DE69832688T patent/DE69832688T2/de not_active Expired - Lifetime
- 1998-07-09 AT AT98933230T patent/ATE311876T1/de not_active IP Right Cessation
- 1998-07-09 MX MXPA04001462A patent/MXPA04001462A/es unknown
- 1998-07-09 ES ES98933230T patent/ES2255170T3/es not_active Expired - Lifetime
- 1998-07-09 PL PL332078A patent/PL191402B1/pl unknown
- 1998-07-09 IL IL12887798A patent/IL128877A0/xx active IP Right Grant
- 1998-07-09 US US09/254,494 patent/US6410747B1/en not_active Expired - Lifetime
-
1999
- 1999-03-08 IL IL128877A patent/IL128877A/en not_active IP Right Cessation
-
2002
- 2002-02-07 US US10/071,488 patent/US6683105B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUP0003852A3 (en) | 2003-04-28 |
CA2264750A1 (en) | 1999-01-21 |
US6683105B2 (en) | 2004-01-27 |
MXPA04001462A (es) | 2005-04-29 |
US20020094999A1 (en) | 2002-07-18 |
AU8293198A (en) | 1999-02-08 |
WO1999002154A1 (en) | 1999-01-21 |
JP4522499B2 (ja) | 2010-08-11 |
US6410747B1 (en) | 2002-06-25 |
SI0949920T1 (sl) | 2006-10-31 |
CZ297533B6 (cs) | 2007-01-03 |
CZ81699A3 (cs) | 2000-01-12 |
PL332078A1 (en) | 1999-08-30 |
EP0949920A1 (de) | 1999-10-20 |
CA2264750C (en) | 2009-06-16 |
EP0949920A4 (de) | 2003-04-23 |
IL128877A0 (en) | 2000-01-31 |
IL128877A (en) | 2007-10-31 |
HUP0003852A2 (hu) | 2001-04-28 |
BR9806184A (pt) | 2001-06-19 |
DE69832688D1 (de) | 2006-01-12 |
EP0949920B1 (de) | 2005-12-07 |
ATE311876T1 (de) | 2005-12-15 |
JP2001500165A (ja) | 2001-01-09 |
AU749088B2 (en) | 2002-06-20 |
AU749088C (en) | 2005-11-03 |
PL191402B1 (pl) | 2006-05-31 |
ES2255170T3 (es) | 2006-06-16 |
DE69832688T2 (de) | 2006-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0949920T3 (da) | Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demens | |
DE69739303D1 (de) | Vorrichtung zur thermischen behandlung von gewebe | |
DK0775007T3 (da) | Blodbehandlingsindretning med forbedret udbytte, og som har en vinklet grænsestyreflade | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
DE69725484D1 (de) | Vorrichtung zur Behandlung von Harninkontinenz | |
DE59610644D1 (de) | Vorrichtung zur Hornhautchirurgie | |
DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
DE69924750D1 (de) | Gerät zur thermischen behandlung von gewebe | |
DE69827424D1 (de) | Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe | |
DE69636674D1 (de) | Vorrichtung zur wärmebehandlung von gewebe | |
DK0934061T3 (da) | Isobutylgaba og dets derivater til behandling af smerte | |
DE69620306D1 (de) | 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege | |
IS8004A (is) | Aðferð við meðhöndlun á vægri vitsmunaskerðingu og til að fyrirbyggja eða tefja Alzheimers-sjúkdóminn | |
DE69711311D1 (de) | Vorrichtung zur thermischen Behandlung von Gewebe | |
DE69630321D1 (de) | Vorrichtung zur örtlichen wärmebehandlung von gewebe | |
DE60139466D1 (de) | Behandlung von diabetes | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
DE50012013D1 (de) | Verfahren und Vorrichtung zur Begrenzung des Drehmomentes zahnärztlicher und chirurgischer Handstücke | |
DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
BG102064A (en) | Method for increasing the retinal blood circulation | |
DE69829217D1 (de) | Vorrichtung zur therapeutischen behandlung von blutgefässen | |
ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
NO963848D0 (no) | Fremgangsmåte for diagnostisering og behandling av HIV-1-infeksjon | |
NO990450D0 (no) | Behandling av sinnslidelser |